Vitti Labs Prevails in Lawsuit Against FDA Over "Minimal Manipulation" Criteria for Section 361 HCT/Ps
PR Newswire —
US District Court decision stands to benefit manufacturers of low-risk human tissue products LIBERTY, Mo., March 27, 2026 /PRNewswire/ -- Vitti Labs (or "the Company") announced today that U.S. District Court Judge Brian C. Wimes granted the Company's motion for summary judgment in its...